BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35412374)

  • 1. Selective Metal Chelation by a Thiosemicarbazone Derivative Interferes with Mitochondrial Respiration and Ribosome Biogenesis in Candida albicans.
    Duan X; Xie Z; Ma L; Jin X; Zhang M; Xu Y; Liu Y; Lou H; Chang W
    Microbiol Spectr; 2022 Jun; 10(3):e0195121. PubMed ID: 35412374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a selective, iron-chelating antifungal compound that disrupts fungal metabolism and synergizes with fluconazole.
    Corrales J; Ramos-Alonso L; González-Sabín J; Ríos-Lombardía N; Trevijano-Contador N; Engen Berg H; Sved Skottvoll F; Moris F; Zaragoza O; Chymkowitch P; Garcia I; Enserink JM
    Microbiol Spectr; 2024 Feb; 12(2):e0259423. PubMed ID: 38230926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hinokitiol chelates intracellular iron to retard fungal growth by disturbing mitochondrial respiration.
    Jin X; Zhang M; Lu J; Duan X; Chen J; Liu Y; Chang W; Lou H
    J Adv Res; 2021 Dec; 34():65-77. PubMed ID: 35024181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chemical screen identifies structurally diverse metal chelators with activity against the fungal pathogen
    Fallah S; Duncan D; Reichl KD; Smith MJ; Wang W; Porco JA; Brown LE; Whitesell L; Robbins N; Cowen LE
    Microbiol Spectr; 2024 Apr; 12(4):e0409523. PubMed ID: 38376363
    [No Abstract]   [Full Text] [Related]  

  • 5. Small molecules restore azole activity against drug-tolerant and drug-resistant
    Alabi PE; Gautier C; Murphy TP; Gu X; Lepas M; Aimanianda V; Sello JK; Ene IV
    mBio; 2023 Aug; 14(4):e0047923. PubMed ID: 37326546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles
    Savage KA; Parquet MC; Allan DS; Davidson RJ; Holbein BE; Lilly EA; Fidel PL
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844048
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Sun Y; Tan L; Yao Z; Gao L; Yang J; Zeng T
    Microbiol Spectr; 2022 Feb; 10(1):e0200721. PubMed ID: 35019705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Chemical Screen Identifies a 2,5-Disubstituted Pyridine as an Inhibitor of Candida albicans Erg11.
    Du Bois AC; Xue A; Pham C; Revie NM; Meyer KJ; Yashiroda Y; Boone C; Nodwell JR; Stogios P; Savchenko A; Robbins N; Iyer KR; Cowen LE
    mSphere; 2022 Jun; 7(3):e0007522. PubMed ID: 35531664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexyl-Aminolevulinate Ethosomes: a Novel Antibiofilm Agent Targeting Zinc Homeostasis in Candida albicans.
    Wang Y; Long W; Zhang F; Zhang M; Zeng K; Zhu X
    Microbiol Spectr; 2022 Dec; 10(6):e0243822. PubMed ID: 36301105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting fungal membrane homeostasis with imidazopyrazoindoles impairs azole resistance and biofilm formation.
    Revie NM; Iyer KR; Maxson ME; Zhang J; Yan S; Fernandes CM; Meyer KJ; Chen X; Skulska I; Fogal M; Sanchez H; Hossain S; Li S; Yashiroda Y; Hirano H; Yoshida M; Osada H; Boone C; Shapiro RS; Andes DR; Wright GD; Nodwell JR; Del Poeta M; Burke MD; Whitesell L; Robbins N; Cowen LE
    Nat Commun; 2022 Jun; 13(1):3634. PubMed ID: 35752611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole resistance in a
    Khandelwal NK; Chauhan N; Sarkar P; Esquivel BD; Coccetti P; Singh A; Coste AT; Gupta M; Sanglard D; White TC; Chauvel M; d'Enfert C; Chattopadhyay A; Gaur NA; Mondal AK; Prasad R
    J Biol Chem; 2018 Jan; 293(2):412-432. PubMed ID: 29158264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergistic antifungal activity of resveratrol with azoles against Candida albicans.
    Wang J; Zhang X; Gao L; Wang L; Song F; Zhang L; Wan Y
    Lett Appl Microbiol; 2021 Jun; 72(6):688-697. PubMed ID: 33550599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milbemycins: more than efflux inhibitors for fungal pathogens.
    Silva LV; Sanguinetti M; Vandeputte P; Torelli R; Rochat B; Sanglard D
    Antimicrob Agents Chemother; 2013 Feb; 57(2):873-86. PubMed ID: 23208712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.
    Nishimoto AT; Sharma C; Rogers PD
    J Antimicrob Chemother; 2020 Feb; 75(2):257-270. PubMed ID: 31603213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic
    Revie NM; Robbins N; Whitesell L; Frost JR; Appavoo SD; Yudin AK; Cowen LE
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Antifungal Effect of a Combination of Iron Deficiency and Calcium Supplementation.
    Ye J; Wang Y; Li X; Wan Q; Zhang Y; Lu L
    Microbiol Spectr; 2022 Jun; 10(3):e0112122. PubMed ID: 35674440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Upc2p-Inducible
    Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
    mBio; 2018 May; 9(3):. PubMed ID: 29789366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.